In vivo experimental results for a novel compound for targeted alpha therapy (IMAGE)
Caption
The figure shows the biodistribution of radioactivity after injecting tumor-bearing mice with [211At]At-NpG-D-PSMA. The results highlight that [211At]At-NpG-D-PSMA accumulates preferentially in tumors while exhibiting low accumulation in the liver and other organs, and therefore holds potential for clinical applications.
Credit
Tomoya Uehara from Chiba University
Usage Restrictions
You are free to share and adapt the material. Attribution is required.
License
Original content